BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 2544809)

  • 1. Increased viral pathogenicity after insertion of a 28S ribosomal RNA sequence into the haemagglutinin gene of an influenza virus.
    Khatchikian D; Orlich M; Rott R
    Nature; 1989 Jul; 340(6229):156-7. PubMed ID: 2544809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonhomologous recombination between the hemagglutinin gene and the nucleoprotein gene of an influenza virus.
    Orlich M; Gottwald H; Rott R
    Virology; 1994 Oct; 204(1):462-5. PubMed ID: 8091680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of an influenza virus A/turkey/Oregon/71 HA insertion variant by the subtilisin-like endoprotease furin.
    Morsy J; Garten W; Rott R
    Virology; 1994 Aug; 202(2):988-91. PubMed ID: 8030261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of influenza B virus hemagglutinin containing multibasic residue cleavage sites.
    Brassard DL; Lamb RA
    Virology; 1997 Sep; 236(2):234-48. PubMed ID: 9325231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis, cloning, and determination of the primary structure of a full-length DNA copy of the gene for influenza A/Alma-Ata/1417/84 virus (H1N1-serovariant HSW1N1) hemagglutinin].
    Beklemishev AB; Nazarova LM; Filimonov NG; Blinov VM; Grinev AA; Chuvakova ZK; Kim EV; Mukazhanova GN
    Mol Gen Mikrobiol Virusol; 1993; (1):24-7. PubMed ID: 8510679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the cleavage activation of the influenza virus hemagglutinin by site-specific mutagenesis.
    Garten W; Vey M; Ohuchi R; Ohuchi M; Klenk HD
    Behring Inst Mitt; 1991 Jul; (89):12-22. PubMed ID: 1930091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico.
    Horimoto T; Rivera E; Pearson J; Senne D; Krauss S; Kawaoka Y; Webster RG
    Virology; 1995 Oct; 213(1):223-30. PubMed ID: 7483266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence analysis of the hemagglutinin gene of H9N2 Korean avian influenza viruses and assessment of the pathogenic potential of isolate MS96.
    Lee CW; Song CS; Lee YJ; Mo IP; Garcia M; Suarez DL; Kim SJ
    Avian Dis; 2000; 44(3):527-35. PubMed ID: 11006999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of adaptation of an avian influenza A (H5N2) virus to a mammalian host.
    Smirnov YA; Lipatov AS; Van Beek R; Gitelman AK; Osterhaus AD; Claas EC
    Acta Virol; 2000 Feb; 44(1):1-8. PubMed ID: 10989685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a foreign epitope by porcine reproductive and respiratory syndrome virus.
    Groot Bramel-Verheije MH; Rottier PJ; Meulenberg JJ
    Virology; 2000 Dec; 278(2):380-9. PubMed ID: 11118361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different hemagglutinin cleavage site variants of H7N7 in an influenza outbreak in chickens in Leipzig, Germany.
    Röhm C; Süss J; Pohle V; Webster RG
    Virology; 1996 Apr; 218(1):253-7. PubMed ID: 8615031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathogenic determinant of influenza virus.
    Rott R
    Vet Microbiol; 1992 Nov; 33(1-4):303-10. PubMed ID: 1481363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of trypsin I as a candidate for influenza A virus and Sendai virus envelope glycoprotein processing protease in rat brain.
    Le TQ; Kawachi M; Yamada H; Shiota M; Okumura Y; Kido H
    Biol Chem; 2006 Apr; 387(4):467-75. PubMed ID: 16606346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic potential of North American H7N2 avian influenza virus: a mutagenesis study using reverse genetics.
    Lee CW; Lee YJ; Senne DA; Suarez DL
    Virology; 2006 Sep; 353(2):388-95. PubMed ID: 16828833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.
    Kobasa D; Takada A; Shinya K; Hatta M; Halfmann P; Theriault S; Suzuki H; Nishimura H; Mitamura K; Sugaya N; Usui T; Murata T; Maeda Y; Watanabe S; Suresh M; Suzuki T; Suzuki Y; Feldmann H; Kawaoka Y
    Nature; 2004 Oct; 431(7009):703-7. PubMed ID: 15470432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia.
    Guo YJ; Krauss S; Senne DA; Mo IP; Lo KS; Xiong XP; Norwood M; Shortridge KF; Webster RG; Guan Y
    Virology; 2000 Feb; 267(2):279-88. PubMed ID: 10662623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells.
    Zhirnov OP; Vorobjeva IV; Saphonova OA; Poyarkov SV; Ovcharenko AV; Anhlan D; Malyshev NA
    J Clin Virol; 2009 Aug; 45(4):322-33. PubMed ID: 19546028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.
    Russ G; Poláková K; Kostolanský F; Styk B; Vancíková M
    Acta Virol; 1987 Sep; 31(5):374-86. PubMed ID: 2891276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies.
    Varecková E; Mucha V; Wharton SA; Kostolanský F
    Arch Virol; 2003 Mar; 148(3):469-86. PubMed ID: 12607099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic determinants for infectivity and pathogenicity of influenza viruses.
    Rott R
    Philos Trans R Soc Lond B Biol Sci; 1980 Feb; 288(1029):393-9. PubMed ID: 6103557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.